About 100 reports

  • 3.1 CATALYST
  • 5.1 DISEASE BACKGROUND

Looks to address the genetic root of PD.

  • Psychotic Disorder
  • Forecast
  • Adamas Pharmaceuticals, Inc.
  • Impax Laboratories, Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • SCHIZOPHRENIA

You can easily book an appointment with one online.

  • Psychotic Disorder
  • World
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • GENE THERAPY TO REVERSE THE PROGRESSION OF PD
  • MARKET OVERVIEW

According to some studies, PD is a neurological disorder caused by genetic mutations.

  • Psychotic Disorder
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • 2.1 Psychosis: An Overview

Genetic factors include a variety of common and rare genetic variants.

  • Psychotic Disorder
  • World
  • Market Size
  • Johnson & Johnson
  • Lundbeck Inc.
  • SCHIZOPHRENIA

You can easily book an appointment with one online.

  • Psychotic Disorder
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • B. Introduction to CNS Disorders
  • Parkinson's Disease

The genetic makeup of E. coli is the best Dementia: Severe impairment of mental functioning.

  • Hospital
  • Psychotic Disorder
  • AstraZeneca PLC
  • Lilly Endowment Inc.
  • Pfizer Inc.
  • 3.1 DISEASE BACKGROUND

Genetic and environmental factors may play a role in the development of PD, as the prevalence of PD is much greater than the incidence (WHO, 2006).

  • Psychotic Disorder
  • Japan
  • United Kingdom
  • United States
  • Forecast
  • 06. Introduction
  • 12.1 Parkinson's Disease: Overview

The disease can be genetically inherited or caused by unknown factors.

  • Psychotic Disorder
  • Biogen Idec Inc.
  • Merck Serono S.A.
  • Novartis AG
  • Pfizer Inc.

ADHD also has a strong genetic component.

  • Psychotic Disorder
  • China
  • Trade
  • AstraZeneca China Inc.
  • Beijing Sihuan Pharmaceutical Co., Ltd.
  • MHDS - MARKET SIZE AND FORECAST 2017-2022

AD is one of the most common types of NDDs.

  • Psychotic Disorder
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.

ADHD also has a strong genetic component.

  • Psychotic Disorder
  • China
  • Market Size
  • Trade
  • Beijing Sihuan Pharmaceutical Co., Ltd.

Schizophrenia

4546 5000 3864
  • A DEEPER KNOWLEDGE OF SCHIZOPHRENIA'S CAUSES COULD HELP FURTHER DRUG DEVELOPMENT
  • Disease Definition and Diagnosis

Rather than one or two disease alleles being implicated across all schizophrenia cases, it is probable that genetic predisposition arises from a large number of copy number variants (CNVs) (Gershon et al., 2011).

  • Psychotic Disorder
  • European Union
  • Japan
  • United States
  • Alkermes plc
  • NEUROLOGICAL AND MOVEMENT DISORDERS

THESE ARE THE COMPLEX DISORDERS AND ARE CAUSED DUE TO VARIOUS GENETIC AND ENVIRONMENTAL FACTORS.

  • Psychotic Disorder
  • World
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • 2.1 DISEASE BACKGROUND

Biological Insights from ## Schizophrenia-Associated Genetic Loci.

  • Psychotic Disorder
  • Japan
  • United Kingdom
  • United States
  • Forecast

Even optogenetic stimulation needs genetic modification.

  • Psychotic Disorder
  • World
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.
  • 2.1 Disease Introduction
  • Secondary symptoms

Research has provided a more elaborate view on the genetic mutation in patients with PD (see Table ##).

  • Psychotic Disorder
  • World
  • Forecast
  • Novartis AG
  • Parkinson Study Group
  • DIAGNOSIS OF THE DISEASE
  • REFERENCES

Tohoku J Exp Med. 2010; ##(##):##-## ##.

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • North America
  • 3.1 ETIOLOGY AND PATHOPHYSIOLOGY
  • 4.2 RISK FACTORS AND COMORBIDITIES

IMAGING ], blood and genetic testing.

  • Psychotic Disorder
  • Alkermes plc
  • Janssen Biotech, Inc.
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • CAUSE OF THE DISEASE
  • INTRODUCTION

Schizophr Res. 2008; ##(##-##):##-## ##.

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Northern Europe
  • Western Europe
  • 3.1 ETIOLOGY AND PATHOPHYSIOLOGY
  • 4.1 DISEASE BACKGROUND

MANY STUDIES HAVE CONCLUDED THAT THE GENETIC COMPONENT IS AN IMPORTANT RISK FACTOR FOR PARKINSON' S DISEASE.

  • Psychotic Disorder
  • Forecast
  • Market Size
  • Merck & Co., Inc.
  • Novartis AG

TABLE OF CONTENTS ##.

  • Psychotic Disorder
  • United States
  • genOway SA
  • Lexicon
  • Taconic Farms, Inc.

## (Cyclooxygenase-## or COX-## or Prostaglandin- Endoperoxide Synthase ## or EC ##. ##. ##. ##) Prostaglandin G/ H Synthase ## (Cyclooxygenase-## or COX-## or Prostaglandin- Endoperoxide Synthase ## or EC ##. ##. ##. ##) ## ## ## ## ## ## ## ## ## ALK Tyrosine Kinase

  • Psychotic Disorder
  • United States
  • Auspex Pharmaceuticals, Inc.
  • Cephalon, Inc.
  • ChemGenex Pharmaceuticals Limited

Global Designer Baby Trends Industry ##.

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Psychotic Disorder
  • World
  • SMALL MOLECULES TO ACTIVATE GCASE FOR PARKINSON'S DISEASE - DRUG PROFILE

Using Pfizer GPS, patients and healthcare professionals can access all support services ##/ ## using one toll-free phone number, ##-##-ELELYSO (##-##-##- ##).

  • Psychotic Disorder
  • Therapy
  • Brazil
  • Product Initiative
  • Protalix BioTherapeutics, Inc.

Gaucher disease is a rare genetic disorder occurs due to lacks an enzyme called glucocerebrosidase.

  • Pharmaceutical
  • Psychotic Disorder
  • United States
  • Product Initiative
  • Genzyme Corporation
  • GENETIC TEST - SCHIZOPHRENIA - PRODUCT STATUS
  • CLIA WAIVED GENETIC TEST - ENDOMETRIOSIS - PRODUCT STATUS

Inborn Gene or Chromosome Alterations Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Inborn Gene or Chromosome Alterations Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Inborn Gene or Chromosome Alterations Diagnostic...

  • Clinical Trial
  • Hospital
  • Nucleic Acid
  • Psychotic Disorder
  • GlobalData's company
  • GLOBAL MARKETS DIRECT REPORT COVERAGE
  • Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Product Development Milestones

The Center for Applied Genomics (CAG) at The Children' s Hospital of Philadelphia (CHOP) founded neuroFix to pursue development of NFC-## following a breakthrough genetic discovery.

  • Psychotic Disorder
  • United States
  • World
  • Product Initiative
  • Addex Therapeutics Ltd
  • Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Product Development Milestones
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

The Center for Applied Genomics (CAG) at The Children' s Hospital of Philadelphia (CHOP) founded neuroFix to pursue development of NFC-## following a breakthrough genetic discovery.

  • Neurological Disorder
  • Psychotic Disorder
  • United States
  • World
  • Product Initiative

Genetic Factors Linked to Parkinson’s Disease PARK## (parkin/ ubiquitin E## ligase) PINK## (PTEN-induced kinase ## protein) GBA (glucocerebrosidase) Promising Biomarkers for Parkinson’s Disease SNCA (?

  • Mental Health
  • Pathology
  • Psychotic Disorder

AN ATTRACTIVE ALTERNATIVE TO THE USE OF GENETICALLY ENGINEERED FIBROBLASTS IS IMMORTALIZED NSCS, WHICH ARE CREATED VIA GENETIC MANIPULATION.

  • Psychotic Disorder
  • North America
  • United States
  • Athersys, Inc.
  • Vericel Corporation